DiogenX
PrivateLast Round
Series A
Extension
Oct 31, 2023
Total Funding Raised
$45.05M
Company Overview
DiogenX is a biotechnology company that develops innovative biologics and regenerative therapies for the treatment of type 1 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DiogenX Comparables
Compare DiogenX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Betavive Ltd. | 85% | |
| Wink Biotherapeutics | 81% | |
| Cour Pharma | 79% | |
DiogenX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 31, 2023 | ||||
| Grant | Oct 1, 2023 | ||||
| Series A | May 10, 2023 | ||||
| Seed | Jun 16, 2020 |
DiogenX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Roche Venture Fund | Series A |
| Boehringer Ingelheim | Seed, Series A |
| Roche Venture Fund | Series A, Series A Extension |
| JDRF | Series A, Seed, Series A Extension |
| Boehringer Ingelheim Venture Fund | Seed, Series A, Series A Extension |
| Omnes Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2023
$2.65M grant from the European Innovation Council Fund
DiogenX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DiogenX's valuation, stock price, and market status.